Øyvind Bruland

Bilde av Øyvind Bruland
English version of this page
Telefon +47-22934767
Brukernavn
Besøksadresse Ullernchausseen 70 None 0372 OSLO
Postadresse Postboks 4950 Nydalen 0424 OSLO

Publikasjoner

  • Boye, Katja; Berner, Jeanne-Marie; Hompland, Ivar; Bruland, Øyvind; Stoldt, Stephan; Sundby Hall, K; Bjerkehagen, Bodil & Hølmebakk, T. (2018). Genotype and risk of tumour rupture in gastrointestinal stromal tumour. British Journal of Surgery.  ISSN 0007-1323.  105(2), s e169- e175 . doi: 10.1002/bjs.10743
  • Hall, Kirsten Sundby; Bruland, Øyvind; Bjerkehagen, Bodil; Zaikova, Olga; Engellau, Jacob; Hagberg, Oskar; Hansson, Lina; Hagberg, Hans; Ahlström, Marie; Knobel, Heidi; Papworth, Karin; Zemmler, Maja; Goplen, Dorota; Bauer, Henrik C.F. & Eriksson, Mikael (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX). European Journal of Cancer.  ISSN 0959-8049.  99, s 78- 85 . doi: 10.1016/j.ejca.2018.05.011
  • Hølmebakk, Søren Torben; Hompland, Ivar; Bjerkehagen, Bodil; Stoldt, Stephan; Bruland, Øyvind; Hall, Kirsten Sundby & Pedersen, Kjetil Boye (2018). Recurrence-free survival after resection of gastric gastrointestinal stromal tumors classified according to a strict definition of tumor rupture: a population-based study. Annals of Surgical Oncology.  ISSN 1068-9265.  25(5), s 1133- 1139 . doi: 10.1245/s10434-018-6353-5
  • Parker, Christopher C.; Coleman, Robert Edward; Sartor, Oliver; Vogelzang, Nicholas J.; Bottomley, David; Heinrich, Daniel; Helle, Svein Inge; O'Sullivan, Joe M.; Fosså, Sophie Dorothea; Chodacki, Aleš; Wiechno, Paweł; Logue, John; Seke, Mihalj; Widmark, Anders; Johannessen, Dag Clement; Hoskin, Peter; James, Nicholas D.; Solberg, Arne; Syndikus, Isabel; Kliment, Jan; Wedel, Steffen; Böhmer, Sibylle; Dall'Oglio, Marcos; Franzén, Lars; Bruland, Øyvind; Petrenciuc, Oana; Staudacher, Karin; Li, Rui & Nilsson, Sten (2018). Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial. European Urology.  ISSN 0302-2838.  73(3), s 353- 360 . doi: 10.1016/j.eururo.2017.06.021
  • Westrøm, Sara; Bønsdorff, Tina Bjørnlund; Bruland, Øyvind & Larsen, Roy H. (2018). Therapeutic effect of α-emitting 224Ra-labeled calcium carbonate microparticles in mice with intraperitoneal ovarian cancer. Translational Oncology.  ISSN 1936-5233.  11(2), s 259- 267 . doi: 10.1016/j.tranon.2017.12.011
  • Westrøm, Sara; Malenge, Marion Masitsa; Jorstad, Ida Sofie; Napoli, Elisa; Bruland, Øyvind; Bønsdorff, Tina Bjørnlund & Larsen, Roy H. (2018). Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice. Journal of labelled compounds & radiopharmaceuticals.  ISSN 0362-4803.  61(6), s 472- 486 . doi: 10.1002/jlcr.3610
  • Hompland, Ivar; Bruland, Øyvind; Hølmebakk, Søren Torben; Poulsen, Jan Peter; Stoldt, Stephan; Hall, Kirsten Sundby & Pedersen, Kjetil Boye (2017). Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort. Acta Oncologica.  ISSN 0284-186X.  56(10), s 1317- 1323 . doi: 10.1080/0284186X.2017.1330555
  • Sartor, Oliver; Coleman, Robert Edward; Nilsson, Sten; Heinrich, Daniel; Helle, Svein Inge; O'Sullivan, Joe M.; Vogelzang, Nicholas J.; Bruland, Øyvind; Kobina, Svetlana; Wilhelm, Scott; Xu, Lei; Shan, Minghua; Kattan, Michael W. & Parker, Christopher (2017). An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223. Annals of Oncology.  ISSN 0923-7534.  28(5), s 1090- 1097 . doi: 10.1093/annonc/mdx044
  • Barøy, Tale; Chilamakuri, Chandra Sekhar Reddy; Lorenz, Susanne; Sun, Jinchang; Bruland, Øyvind; Myklebost, Ola & Meza-Zepeda, Leonardo (2016). Genome analysis of osteosarcoma progression samples identifies FGFR1 overexpression as a potential treatment target and CHM as a candidate tumor suppressor gene. PLoS ONE.  ISSN 1932-6203. . doi: 10.1371/journal.pone.0163859

Se alle arbeider i Cristin

  • Herlofson, Bente Brokstad; Kjølle, Gry Karina; Westgaard, Kristine Løken; Løndalen, Ayca & Bruland, Øyvind (2018). Osteonecrosis of the jaw in a patient with bone metastatic prostate cancer after long-term bisphosphonate treatment with severe deterioration following radium-223. Clinical Genitourinary Cancer.  ISSN 1558-7673.  s 1- 4 . doi: 10.1016/j.clgc.2018.05.003

Se alle arbeider i Cristin

Publisert 13. apr. 2011 11:36 - Sist endret 27. mai 2011 15:57